Bettina Temmesfeld-Wollbrück Selected Research

Bettina Temmesfeld-Wollbrück Research Topics

4	Neoplasms (Cancer) 12/2019 - 09/2009
4	Sepsis (Septicemia) 07/2009 - 12/2005
3	Inflammation (Inflammations) 07/2009 - 09/2003
3	Septic Shock (Toxic Shock Syndrome) 11/2007 - 09/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2012 - 09/2009
1	Adenocarcinoma of Lung 11/2020
1	Malignant Pleural Effusion 01/2020
1	Pleural Effusion (Pleural Effusions) 12/2019
1	Histoplasmosis 05/2017
1	Sarcoidosis (Schaumann Disease) 05/2017
1	Diarrhea 03/2012
1	Paronychia 03/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2011
1	Breast Neoplasms (Breast Cancer) 12/2011
1	Lung Neoplasms (Lung Cancer) 12/2011
1	Critical Illness (Critically Ill) 07/2009
1	Respiratory Insufficiency (Respiratory Failure) 02/2009
1	Coma (Comas) 02/2009
1	Infections 11/2007
1	Shock 04/2007

4	AdrenomedullinIBA 07/2009 - 12/2005
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 03/2012
2	Docetaxel (Taxotere)FDA Link 12/2011 - 09/2009
2	Peptides (Polypeptides)IBA 11/2007 - 04/2007
1	Pemetrexed (MTA)FDA Link 11/2020
1	Thyroid Nuclear Factor 1IBA 11/2020
1	S 10 (S-10)IBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 05/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2012
1	Gemcitabine FDA Link 12/2011
1	Cisplatin (Platino)FDA LinkGeneric 09/2009
1	Virulence Factors (Pathogenicity Factors)IBA 07/2009
1	Ethanol (Ethyl Alcohol)IBA 02/2009
1	Charcoal (Charbon)IBA 02/2009
1	ExotoxinsIBA 04/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2003
1	EmulsionsIBA 09/2003
1	LipidsIBA 09/2003